Effects of anti-IL-1α, anti-IL-1β, anti-IL-18 and anti-IL-1RI antibodies on combined smoke and virus-induced airway inflammation in mice
Hannes Bucher (Biberach an der Riss, Germany), Hannes Bucher, Martina Keck, Michel Przibilla, David Lamb, David Wyatt, Mareike Wittenbrink, Klaus Fuchs, Birgit Jung, Klaus J. Erb, Daniel Peter
Source: International Congress 2015 – New models for treating airway diseases
Session: New models for treating airway diseases
Session type: Poster Discussion
Number: 3577
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hannes Bucher (Biberach an der Riss, Germany), Hannes Bucher, Martina Keck, Michel Przibilla, David Lamb, David Wyatt, Mareike Wittenbrink, Klaus Fuchs, Birgit Jung, Klaus J. Erb, Daniel Peter. Effects of anti-IL-1α, anti-IL-1β, anti-IL-18 and anti-IL-1RI antibodies on combined smoke and virus-induced airway inflammation in mice. Eur Respir J 2015; 46: Suppl. 59, 3577
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014
Effect of treatment with anti-IgE antibody on airway inflammation in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 203s Year: 2003
Evaluation of bronchial hyperreactivity and other functional parameters in severe asthma patients treated with anti-interleukin-5 monoclonal antibody (IL5) Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice Source: International Congress 2016 – Immune responses in the lung Year: 2016
Increased total, secretory and NTHi-specific IgA in the COPD airway Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015
Assesment of the effects of tocilizumab, adalimumab and steroid in LPS induced acute lung inflammation Source: International Congress 2016 – Airway response to infection Year: 2016
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015
Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014
The effects of efalizumab, an anti-CD11a monoclonal antibody (hu1124), on allergen-induced airway inflammation in atopic asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 350s Year: 2001
The rationale for treating allergic asthma with anti-IgE Source: Eur Respir Rev 2007; 16: 61-66 Year: 2007
Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014
Cytokine production of leukocytes in response to respiratory syncytial virus is suppressed by cigarette smoking and in COPD Source: International Congress 2016 – Airway response to infection Year: 2016
LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena Source: Eur Respir J, 56 (4) 2000117; 10.1183/13993003.00117-2020 Year: 2020
Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015
Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011
The effect of anti-IL-33 antibody and soluble ST2 in a murine model of allergic asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013